Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples